Medpace Holdings Inc buy UBS Group AG
Start price
15.02.24
/
50%
€369.50
Target price
15.02.25
€419.64
Performance (%)
-1.35%
Price
02.05.24
€364.50
Summary
This prediction is currently active. With a performance of -1.35%, the BUY prediction for Medpace Holdings Inc by UBS_Group_AG is down slightly. This prediction currently runs until 15.02.25. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Medpace Holdings Inc | 0.330% | 0.330% |
| iShares Core DAX® | 0.000% | -2.064% |
| iShares Nasdaq 100 | 0.626% | -2.884% |
| iShares Nikkei 225® | 1.568% | -5.892% |
| iShares S&P 500 | 0.334% | -2.281% |
Comments by UBS_Group_AG for this prediction
In the thread Medpace Holdings Inc diskutieren
Medpace Holdings, Inc. (NASDAQ: MEDP) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $452.00 price target on the stock, up previously from $282.00.
Ratings data for MEDP provided by MarketBeat